Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Controlled, Double-Blinded, Multi-Center, Phase 1/2b Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing

NCT05560477 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT05560477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05560477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Controlled, Double-Blinded, Multi-Center, Phase 1/2b Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing
Lead sponsor
University of Cincinnati
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 26, 2023
Completion date
June 30, 2027
Enrollment
74 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

meniscus tear